Skip to content
Society for Biopsychosocial Science and Medicine
  • Meetings
    • 2025 Annual Meeting
    • Clinical Science Webinar Series
    • SBSM 2024 Virtual Disease A Year (DAY) Meeting
    • Past Annual Meetings
    • SBSM Connects Calls
  • Groups & Networking
    • Special Interest Groups
    • Committees
  • News and Stories
    • News Releases
    • Newsletters
    • President’s Message
  • SBSM Journal
  • Specialty Resources
    • Educational Resources
    • Careers
  • Awards & Scholarships
  • Events
  • About
    • SBSM Membership
    • SBSM Strategic Plan
    • SBSM Bylaws
    • Leadership
      • Past Presidents
    • Donate
    • Contact
    • Ethical Principles & Code of Conduct
    • FCOI
FacebookTwitter
  • Join Us
  • Contact
Society for Biopsychosocial Science and Medicine
Member Login
  • Meetings
    • 2025 Annual Meeting
    • Clinical Science Webinar Series
    • SBSM 2024 Virtual Disease A Year (DAY) Meeting
    • Past Annual Meetings
    • SBSM Connects Calls
  • Groups & Networking
    • Special Interest Groups
    • Committees
  • News and Stories
    • News Releases
    • Newsletters
    • President’s Message
  • SBSM Journal
  • Specialty Resources
    • Educational Resources
    • Careers
  • Awards & Scholarships
  • Events
  • About
    • SBSM Membership
    • SBSM Strategic Plan
    • SBSM Bylaws
    • Leadership
      • Past Presidents
    • Donate
    • Contact
    • Ethical Principles & Code of Conduct
    • FCOI

SBSM Publication Policy

Home / SBSM Publication Policy

SBSM Publication Policy

The Society for Biopsychosocial Science and Medicine relies upon its diverse and engaged membership to sustain its reputation for advancing the scientific understanding and multidisciplinary integration of biological, psychological, behavioral, and social factors in human health and disease. SBSM is dedicated to disseminating this understanding through educational activities and publications.

This document is intended to provide guidance regarding APS’s policy on the publication of papers arising through the activities of and on behalf of an SBSM working group, task force, committee, or special interest group (SIG). In these circumstances, it is appropriate to acknowledge APS’s role in the process of creating a publication, and for situations where APS’s endorsement is sought.

This policy extends to but is not limited to, papers that may serve as a review of the literature, best practices, or state-of-the-science, a strategic plan for future research in psychosomatic science and medicine, a response to a specific health policy or practice, or serve as an official policy of APS.

Several principles should underlie these publications:

  1. The content is relevant and consistent with APS’s mission.
  2. The authorship process has been inclusive at both the planning, writing, and review stages to incorporate the perspectives and experiences of SBSM members.
  3. Any conflict of interest in the content or the authorship is fully disclosed.

Recommended Steps:

  1. Concept Proposal and Review: Before beginning a paper on behalf of SBSM (SIG, committee, working group, or task force), an abstract/concept should be submitted to the SBSM Council via the Executive Director. Groups requesting the endorsement of SBSM will have their paper reviewed by Council and if approved, agree to consider comments from the SBSM membership collected during an open comment period. The proposal should include the paper’s objectives and relevance to the SBSM mission and scope/charge/mandate of the SIG, committee, working group, or task force. The proposal should specify the proposed methods, analyses, and expected outcomes; target journal/publication outlet with alternatives; authorship structure and means for reflecting diversity, equity, and inclusion of authors, and project timeline. The Council will approve the concept proposal or not and provide feedback within one month.
  2. Writing the paper: For papers initiated by SBSM SIGs and committees, all members of the group should be invited to participate in the writing process. For a paper initiated by a working group or task force, this might include an open invitation to the entire SBSM membership or a relevant SIG to be involved in the writing process. Members should be given at least two weeks to indicate an interest in participation. It is acceptable to limit the number of individuals in a writing group for pragmatic reasons, but deliberate and intentional actions should be taken to form a diverse writing group.
  3. Publication Review: After the manuscript has been approved by the writing committee and sponsoring group (e.g., SIG or committee), the corresponding author should submit the final draft manuscript to the SBSM Council via the Executive Director, and indicate whether review/approval from the Council (Part a below) or SBSM Membership (Part b below) is sought.
    1. Review/Approval by Council (Disclaimer that the paper does not reflect the views of the entire SBSM membership): For all papers published on behalf of APS, the Council will have an opportunity to review the paper and have editorial authority over the paper. The Council will respond to the first author on the paper within 4 weeks of submission. Approval by at least 2/3 of the Council is required. If the Council does not approve the paper, the author(s) may
      1. revise the paper accordingly, or
      2. withdraw APS’s association with the paper before journal submission, unless SBSM has provided financial support to the writing group, in which case the SBSM Council’s decision regarding the future of the paper is final.
    2. Review/Approval by SBSM Membership: For papers requiring review by the entire membership, the manuscript will be posted on the SBSM website, and the full membership will be invited to comment on the paper. Members will be given a month to post comments. The comments from SBSM members and the response by the writing committee will be reviewed by three members of the SBSM Council (and a designated editor from Psychosomatic Medicine if that is the target journal) to confirm that appropriate suggestions have been incorporated or dissenting opinions are acknowledged. The Council will make final approval of the manuscript per section 3a above.

 

  1. Conflict of Interest by reviewers: Council members involved as authors on the paper must recuse themselves from commenting or voting on the matter. If this reduces that voting group to less than a quorum, the voting body will be supplemented from the list of Past Presidents, beginning with the most recent.

 

Authorship:

Alternate forms of authorship might be considered. The preferred format, especially for policy statements and reports from large committees, would first list the named SBSM working group, committee or SIG followed by members of the writing committee, as in: “SBSM Affect Science in Medicine Special Interest Group, John Doe (chair), Jane Smith, …”. In the alternative format, the authors of the writing group are followed by the named SBSM working group, committee or SIG, for example, “Jane Doe and Richard Roe on behalf of the SBSM LGBTQ+ Special Interest Group.” The alternative format should include justification of why the preferred format is infeasible (e.g. journal policy) or why the alternative is more appropriate. Included in the considerations of the two alternatives should be issues of conflict of interest, specifically recognizing that authorship is a benefit. Authorship plans should be documented in advance using the usual standards that recognize the level of involvement. An appendix may list all group members.

Acknowledgement/Disclaimer:

Any paper written on “behalf of APS” must be reviewed and approved by the SBSM Council.

If the SBSM Council approves the manuscript but the SBSM membership does not review and comment on the manuscript, then the authors should acknowledge: “This paper was approved as an Society for Biopsychosocial Science and Medicine (APS) publication by the SBSM Council.”

If the SBSM Council approves the manuscript and the SBSM membership is also given the opportunity to review and comment on the manuscript, the authors should acknowledge: “This paper was reviewed by the membership of the Society for Biopsychosocial Science and Medicine (APS) and is endorsed by the SBSM Council.”

 

Note: Disclaimer language can be modified by the Council at their discretion.

 

Approved by SBSM Council September 18, 2020

 

Latest News

  • January Presidents Message January 20, 2025
  • Looking Back, Looking Forward: Year 1 Highlights of our 2024-2027 Strategic Plan and Strategic Actions for the Coming Year January 17, 2025
  • 2025 Annual Meeting Registration Now Open! January 14, 2025
  • SBSM 2025 Slate January 10, 2025
  • SBSM Affect Science in Medicine SIG Meeting – January 15, 2025 at 11:00am EST January 7, 2025

Connect with SBSM

Connect on Facebook
Connect on Threads
Connect on Twitter
Connect on LinkedIn
Connect on SBSM Collaborates
Connect on Instagram
SBSM Logo_noshadow_resize

6728 Old McLean Village Drive
McLean, Virginia 22101

(703) 884-9562

703-556-8729

info@thesbsm.org

  • Meetings
    • 2025 Annual Meeting
    • Clinical Science Webinar Series
    • SBSM 2024 Virtual Disease A Year (DAY) Meeting
    • Past Annual Meetings
    • SBSM Connects Calls
  • Groups & Networking
    • Special Interest Groups
    • Committees
  • News and Stories
    • News Releases
    • Newsletters
    • President’s Message
  • SBSM Journal
  • Specialty Resources
    • Educational Resources
    • Careers
  • Awards & Scholarships
  • Events
  • About
    • SBSM Membership
    • SBSM Strategic Plan
    • SBSM Bylaws
    • Leadership
      • Past Presidents
    • Donate
    • Contact
    • Ethical Principles & Code of Conduct
    • FCOI
  • Join Us
  • Contact

Join our Email List

Sign up to receive updates in your inbox!
Join Our Email List

© 2025 Society for Biopsychosocial Science and Medicine     Privacy Policy     Accessibility Statement

Website by Yoko Co

Scroll To Top